BACKGROUND: Prior estimates of lifetime risk (LTR) for cardiovascular disease (CVD) examined the impact of blood pressure (BP) at the index age and did not account for changes in BP over time. We examined how changes in BP during middle age affect LTR for CVD, coronary heart disease, and stroke. METHODS AND RESULTS: Data from 7 diverse US cohort studies were pooled. Remaining LTRs for CVD, coronary heart disease, and stroke were estimated for white and black men and women with death free of CVD as a competing event. LTRs for CVD by BP strata and by changes in BP over an average of 14 years were estimated. Starting at 55 years of age, we followed up 61 585 men and women for 700 000 person-years. LTR for CVD was 52.5% (95% confidence interval, 51.3-53.7) for men and 39.9% (95% confidence interval, 38.7-41.0) for women. LTR for CVD was higher for blacks and increased with increasing BP at index age. Individuals who maintained or decreased their BP to normal levels had the lowest remaining LTR for CVD, 22% to 41%, compared with individuals who had or developed hypertension by 55 years of age, 42% to 69%, suggesting a dose-response effect for the length of time at high BP levels. CONCLUSIONS: Individuals who experience increases or decreases in BP in middle age have associated higher and lower remaining LTR for CVD. Prevention efforts should continue to emphasize the importance of lowering BP and avoiding or delaying the incidence of hypertension to reduce the LTR for CVD.
BACKGROUND: Prior estimates of lifetime risk (LTR) for cardiovascular disease (CVD) examined the impact of blood pressure (BP) at the index age and did not account for changes in BP over time. We examined how changes in BP during middle age affect LTR for CVD, coronary heart disease, and stroke. METHODS AND RESULTS: Data from 7 diverse US cohort studies were pooled. Remaining LTRs for CVD, coronary heart disease, and stroke were estimated for white and black men and women with death free of CVD as a competing event. LTRs for CVD by BP strata and by changes in BP over an average of 14 years were estimated. Starting at 55 years of age, we followed up 61 585 men and women for 700 000 person-years. LTR for CVD was 52.5% (95% confidence interval, 51.3-53.7) for men and 39.9% (95% confidence interval, 38.7-41.0) for women. LTR for CVD was higher for blacks and increased with increasing BP at index age. Individuals who maintained or decreased their BP to normal levels had the lowest remaining LTR for CVD, 22% to 41%, compared with individuals who had or developed hypertension by 55 years of age, 42% to 69%, suggesting a dose-response effect for the length of time at high BP levels. CONCLUSIONS: Individuals who experience increases or decreases in BP in middle age have associated higher and lower remaining LTR for CVD. Prevention efforts should continue to emphasize the importance of lowering BP and avoiding or delaying the incidence of hypertension to reduce the LTR for CVD.
Authors: Donald M Lloyd-Jones; Martin G Larson; Eric P Leip; Alexa Beiser; Ralph B D'Agostino; William B Kannel; Joanne M Murabito; Ramachandran S Vasan; Emelia J Benjamin; Daniel Levy Journal: Circulation Date: 2002-12-10 Impact factor: 29.690
Authors: A Kagan; B R Harris; W Winkelstein; K G Johnson; H Kato; S L Syme; G G Rhoads; M L Gay; M Z Nichaman; H B Hamilton; J Tillotson Journal: J Chronic Dis Date: 1974-09
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: John T Wilkins; Kunal N Karmali; Mark D Huffman; Norrina B Allen; Hongyan Ning; Jarett D Berry; Daniel B Garside; Alan Dyer; Donald M Lloyd-Jones Journal: Int J Epidemiol Date: 2015-08-14 Impact factor: 7.196
Authors: Kai Lin; Donald M Lloyd-Jones; Ying Liu; Biao Lu; Huadan Xue; Yining Wang; Debiao Li; James C Carr Journal: Int J Cardiovasc Imaging Date: 2013-10-30 Impact factor: 2.357
Authors: Lindsay R Pool; Hongyan Ning; John Wilkins; Donald M Lloyd-Jones; Norrina B Allen Journal: JAMA Cardiol Date: 2018-11-01 Impact factor: 14.676
Authors: John Henry Dasinger; Suttira Intapad; Miles A Backstrom; Anthony J Carter; Barbara T Alexander Journal: Am J Physiol Renal Physiol Date: 2016-05-04
Authors: Nisha I Parikh; Margareta Norberg; Erik Ingelsson; Sven Cnattingius; Ramachandran S Vasan; Magnus Domellöf; Jan Håkan Jansson; Anna-Karin Edstedt Bonamy Journal: Hypertension Date: 2017-01-30 Impact factor: 10.190